CCT measurements a must for all glaucoma patients

Article

Central corneal thickness (CCT) measurements should be carries out on all glaucoma patients in order to help set an accurate target intraocular pressure (IOP) range.

Central corneal thickness (CCT) measurements should be carries out on all glaucoma patients in order to help set an accurate target intraocular pressure (IOP) range, according to Madhu Nagar and colleagues from the Clayton Hospital, West Yorkshire, UK.

A team of researchers carried out a retrospective analysis of existing glaucoma patients at the Clayton and Dewsbury Hospitals, UK between April 2002 and September 2006. IOP was measured using Goldman Tonometry and CCT measured with a hand-held ultrasound pachymeter.

A total of 168 patients were identified for the study. The average CCT was 538.6 µm and corneas were thicker in ocular hypertension patients than in those with normal tension glaucoma. IOP measurements were also found to be higher in patients with thicker corneas. Forty-nine eyes of 35 patients had two CCT readings taken over a period of time but no clinically significant differences were found between the two measurements.

The team suggest that CCT measurements be carried out on all glaucoma patients since the results can help set accurate target IOP ranges, which can in turn help prevent over-treatment.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.